2020 has been a challenging year for all industries. For pharma and its HCP customers even more so. All eyes are on the companies developing vaccines and drugs for treatment of COVID-19, while doctors have closed their doors for pharma reps. Long established processes have been disrupted and complex market strategies have been rendered useless. Each pharma no matter big or small, innovative, or generic, had to improvise and come up with contingency plans to save the year. Some have been slower waiting for the old ways to come back, others have been more agile experimenting with digital and expanding boundaries, most are in the middle digitally curious but not risking too much.

Not Digital Solutions alone, but Business Solutions that add Value to Customers delivered via Digital Platforms

Yesterday I received a WhatsApp from a famous shoe...

Contact Us
Terms of Service
Privacy Statement

Facebook

Twitter

Youtube

Healthcare Trends

Navigating the Jungle: How to Turn Field Chaos Into Your Brand’s Competitive Advantage

To navigate chaos, you first need to know who...

Cipla appoints Shivam Puri as CEO of One India Business

Shivam Puri has been appointed Chief Executive Officer of...

Mounjaro Upends Semaglutide Gold Rush: IPM May 2026

1. The Eli Lilly & Mounjaro Disruption: A New...

Why Pharma Field Force Fails: The Missing MAP of Motivation

Executive Summary Most healthcare organizations fail at execution, not...

Online Pharmacy:Modest but Accelerating Share of the Retail Pharma Market

India’s pharmaceutical retail landscape remains one of the world’s...

Marketing

Navigating the Jungle: How to Turn Field Chaos Into Your Brand’s Competitive Advantage

To navigate chaos, you first need to know who...

Cipla appoints Shivam Puri as CEO of One India Business

Shivam Puri has been appointed Chief Executive Officer of...

Mounjaro Upends Semaglutide Gold Rush: IPM May 2026

1. The Eli Lilly & Mounjaro Disruption: A New...

Why Pharma Field Force Fails: The Missing MAP of Motivation

Executive Summary Most healthcare organizations fail at execution, not...

Online Pharmacy:Modest but Accelerating Share of the Retail Pharma Market

India’s pharmaceutical retail landscape remains one of the world’s...

Policies/Sales

Navigating the Jungle: How to Turn Field Chaos Into Your Brand’s Competitive Advantage

To navigate chaos, you first need to know who...

Cipla appoints Shivam Puri as CEO of One India Business

Shivam Puri has been appointed Chief Executive Officer of...

Mounjaro Upends Semaglutide Gold Rush: IPM May 2026

1. The Eli Lilly & Mounjaro Disruption: A New...

Why Pharma Field Force Fails: The Missing MAP of Motivation

Executive Summary Most healthcare organizations fail at execution, not...

Online Pharmacy:Modest but Accelerating Share of the Retail Pharma Market

India’s pharmaceutical retail landscape remains one of the world’s...

Strategy

Navigating the Jungle: How to Turn Field Chaos Into Your Brand’s Competitive Advantage

To navigate chaos, you first need to know who...

Cipla appoints Shivam Puri as CEO of One India Business

Shivam Puri has been appointed Chief Executive Officer of...

Mounjaro Upends Semaglutide Gold Rush: IPM May 2026

1. The Eli Lilly & Mounjaro Disruption: A New...

Why Pharma Field Force Fails: The Missing MAP of Motivation

Executive Summary Most healthcare organizations fail at execution, not...

Online Pharmacy:Modest but Accelerating Share of the Retail Pharma Market

India’s pharmaceutical retail landscape remains one of the world’s...

Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
- FFE+CEO RT
- BrandStorm
Solutions & Pricing
Partner

Hot topics

What about Indian Pharma?

Articles by K. Hariram, Vivek Hattangadi, Soham Wagh, Dr. Rajshri Jobanputra, and Rashesh Patel

IMS Health Market Reflection Report for July 2016

The Indian Pharmaceutical Market (IPM) was valued atRs. 10,025 crores in the month of July 2016 clocking a 14.7% growth over same period last year (SPLY). This was the first time ever the market crossed the 10,000 crore mark in a single month.

Indian Pharma – The Emerging Role of Hybrid Sales Model

COVID-19 has accelerated the shift in how pharma was engaging with HCPs, professional organisations and even patients in India from a sales to more of a scientific, unbiased and balanced marketing communications. As one of the business leader from a prominent MNC said, “For the first time we are seeing a certain shift in HCP’s preference for scientific communication for innovators companies. MSLs and scientific operation teams will be playing a key role in the near future.”